Alexander Nowak
Stock Analyst at Craig-Hallum
(2.60)
# 2,277
Out of 5,005 analysts
45
Total ratings
44.44%
Success rate
5.77%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $8.71 | +152.58% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $167.35 | -6.18% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $7.02 | +142.17% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $29.98 | +90.13% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $50.51 | -46.55% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $15.19 | -1.25% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $7.07 | +13.15% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.84 | +878.26% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $14.71 | +239.90% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $280 → $160 | $16.35 | +878.59% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $56.72 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.93 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $3.14 | +250.32% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $62.95 | +74.74% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.46 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $3.19 | +9,304.39% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.36 | +170.27% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $8.71
Upside: +152.58%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $167.35
Upside: -6.18%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $7.02
Upside: +142.17%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $29.98
Upside: +90.13%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $50.51
Upside: -46.55%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $15.19
Upside: -1.25%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $7.07
Upside: +13.15%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.84
Upside: +878.26%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $14.71
Upside: +239.90%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280 → $160
Current: $16.35
Upside: +878.59%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $56.72
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.93
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $3.14
Upside: +250.32%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $62.95
Upside: +74.74%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.46
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $3.19
Upside: +9,304.39%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $10.36
Upside: +170.27%